Sam Altman’s Startup: Brain Reading with Sound Waves
- Sam altman, CEO of OpenAI, is launching a brain-computer interface (BCI) startup called Merge Labs, co-founded with Alex Blania.
- Merge Labs is currently seeking funding, anticipating raising hundreds of millions of dollars from investors including OpenAI.
- Shapiro's hiring is a important indicator of Merge Labs' technical direction.
“`html
Sam Altman Launches Merge Labs with Biomolecular engineering Expert
What Happened
Sam altman, CEO of OpenAI, is launching a brain-computer interface (BCI) startup called Merge Labs, co-founded with Alex Blania. He has appointed Mikhail Shapiro, an award-winning biomolecular engineer from Caltech, to a key leadership role within the founding team.
Merge Labs is currently seeking funding, anticipating raising hundreds of millions of dollars from investors including OpenAI. Initial reporting on the funding round appeared in the Financial Times.
Why It Matters: A Non-Invasive Approach to BCIs
Shapiro’s hiring is a important indicator of Merge Labs’ technical direction. His research at Caltech focuses on non-invasive methods for neural imaging and control, specifically utilizing ultrasound technology. This contrasts with companies like Neuralink, which require invasive surgical procedures.
The potential of non-invasive BCIs is substantial. It could open up applications in areas like:
- Neurological Rehabilitation: Assisting patients recovering from stroke or spinal cord injuries.
- Mental Health: Developing new therapies for conditions like depression and anxiety.
- Human-Computer Interaction: Creating more intuitive and seamless interfaces.
Mikhail Shapiro’s Expertise
Mikhail Shapiro’s lab at Caltech has made significant advancements in biomolecular technology. His work centers around:
- Non-invasive neural Imaging: Developing techniques to visualize brain activity without surgery.
- Ultrasound Neuromodulation: Using focused ultrasound to stimulate or inhibit specific brain regions.
- Gene Therapy for Ultrasound Enhancement: Employing gene therapy to make cells more visible to ultrasound, improving imaging resolution.
Timeline and Next Steps
| Date | Event |
|---|---|
| Recent | Sam Altman and Alex Blania found Merge Labs. |
| Recent | Mikhail shapiro joins Merge Labs as a key founding member. |
| Ongoing | Merge Labs is actively seeking funding from OpenAI and other investors. |
| Future | Merge Labs will likely announce further details regarding it’s technology and development roadmap. |
The company is expected to publicly detail its technology and goals as funding is secured and development progresses.
FAQs
what is a brain-computer interface (BCI)?
A BCI is a system that allows direct communication between the brain and an external device. This can involve reading signals from the brain to control a computer or other technology, or sending signals to the brain to restore lost function.
How does Merge Labs’ approach differ from Neuralink?
Neuralink focuses on invasive BCIs, requiring surgical implantation